Jiajun Zhang

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ying Lv · 3 shared papers, 2026 · strength 0.78
   • Paper Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformati… DOI 10.3390/biom16050685↗
   • Paper A pH-responsive liposomal nanoplatform for reprogramming lactate metabolism and immunogenic activation in pancreatic ca… DOI 10.1016/j.biomaterials.2026.124401↗
   • Paper STING Agonist-Modified Tumor Targeting Photosensitizer Remodels Cancer-Associated Fibroblasts to Potentiate Photoimmuno… DOI 10.1002/advs.202520547↗
2. Jialun Wang · 1 shared paper, 2026 · strength 0.32
   • Paper Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformati… DOI 10.3390/biom16050685↗
3. Yin Zhang · 1 shared paper, 2026 · strength 0.24
   • Paper A pH-responsive liposomal nanoplatform for reprogramming lactate metabolism and immunogenic activation in pancreatic ca… DOI 10.1016/j.biomaterials.2026.124401↗
4. Yixuan Zhang · 1 shared paper, 2026 · strength 0.24
   • Paper A pH-responsive liposomal nanoplatform for reprogramming lactate metabolism and immunogenic activation in pancreatic ca… DOI 10.1016/j.biomaterials.2026.124401↗
5. Yu Zhao · 1 shared paper, 2026 · strength 0.24
   • Paper A pH-responsive liposomal nanoplatform for reprogramming lactate metabolism and immunogenic activation in pancreatic ca… DOI 10.1016/j.biomaterials.2026.124401↗
6. Xiaoping Zou · 1 shared paper, 2026 · strength 0.24
   • Paper A pH-responsive liposomal nanoplatform for reprogramming lactate metabolism and immunogenic activation in pancreatic ca… DOI 10.1016/j.biomaterials.2026.124401↗
7. Y. Zhang · 1 shared paper, 2026 · strength 0.23
   • Paper STING Agonist-Modified Tumor Targeting Photosensitizer Remodels Cancer-Associated Fibroblasts to Potentiate Photoimmuno… DOI 10.1002/advs.202520547↗
8. Shijin Xu · 1 shared paper, 2025 · strength 0.21
   • Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗
9. Yixuan Zhang · 1 shared paper, 2025 · strength 0.21
   • Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗
10. Ziwei Zhang · 1 shared paper, 2025 · strength 0.21
    • Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗
11. Li Lin · 1 shared paper, 2025 · strength 0.21
    • Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗
12. Ying Lv · 1 shared paper, 2025 · strength 0.21
    • Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗
13. Shu Zhang · 1 shared paper, 2025 · strength 0.21
    • Paper Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic … DOI 10.1186/s12951-025-03795-z↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.